Skip to main content

Table 2 Olaparib administration doses (mg) per BSA

From: Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: study protocol

BSA (m2)

Olaparib administration doses (mg b.i.d.)

1st dose

(62.5 mg/m2)

2nd dose

(125 mg/m2)

3rd dose

(187.5 mg/m2)

0.40 ≤ BSA < 0.50

25

50

75

0.50 ≤ BSA < 0.60

25

50

75

0.60 ≤ BSA < 0.70

25

75

100

0.70 ≤ BSA < 0.80

25

75

125

0.80 ≤ BSA < 0. 90

50

100

150

0.90 ≤ BSA < 1.00

50

100

150

1.00 ≤ BSA < 1.10

50

125

175

1.10 ≤ BSA < 1.20

50

125

200

1.20 ≤ BSA < 1.30

75

150

225

1.30 ≤ BSA < 1.40

75

150

225

1.40 ≤ BSA < 1.50

75

175

250

1.50 ≤ BSA < 1.60

75

175

275

1.60 ≤ BSA

100

200

300